These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7756648)

  • 21. Local delivery of r-hirudin by a double-balloon perfusion catheter prevents mural thrombosis and minimizes platelet deposition after angioplasty.
    Meyer BJ; Fernández-Ortiz A; Mailhac A; Falk E; Badimon L; Michael AD; Chesebro JH; Fuster V; Badimon JJ
    Circulation; 1994 Nov; 90(5):2474-80. PubMed ID: 7955205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of growth of thrombus on fresh mural thrombus. Targeting optimal therapy.
    Meyer BJ; Badimon JJ; Mailhac A; Fernández-Ortiz A; Chesebro JH; Fuster V; Badimon L
    Circulation; 1994 Nov; 90(5):2432-8. PubMed ID: 7955200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. r-Hirudin inhibits platelet-dependent thrombosis during cardiopulmonary bypass in baboons.
    van Wyk V; Neethling WM; Badenhorst PN; Kotzé HF
    J Cardiovasc Surg (Torino); 1998 Oct; 39(5):633-9. PubMed ID: 9833724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the antithrombotic effect of PEG-hirudin and heparin in a human ex vivo model of arterial thrombosis.
    Bossavy JP; Sakariassen KS; Rübsamen K; Thalamas C; Boneu B; Cadroy Y
    Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1348-53. PubMed ID: 10323789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antithrombotic effects of orally active synthetic antagonist of activated factor X in nonhuman primates.
    Yokoyama T; Kelly AB; Marzec UM; Hanson SR; Kunitada S; Harker LA
    Circulation; 1995 Aug; 92(3):485-91. PubMed ID: 7634464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reocclusion after thrombolysis: a problem solved by hirudin?
    Rübsamen K; Eschenfelder V
    Blood Coagul Fibrinolysis; 1991 Feb; 2(1):97-100. PubMed ID: 1773004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trial.
    Topol EJ; Fuster V; Harrington RA; Califf RM; Kleiman NS; Kereiakes DJ; Cohen M; Chapekis A; Gold HK; Tannenbaum MA
    Circulation; 1994 Apr; 89(4):1557-66. PubMed ID: 8149521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction in vascular lesion formation by hirudin secreted from retrovirus-transduced confluent endothelial cells on vascular grafts in baboons.
    Lundell A; Kelly AB; Anderson J; Marijianowski M; Rade JJ; Hanson SR; Harker LA
    Circulation; 1999 Nov; 100(19):2018-24. PubMed ID: 10556229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antithrombotic action of recombinant hirudin in a venous thrombosis model.
    Raake W; Klauser RJ; Elling H; Zeiller P
    Haemostasis; 1991; 21 Suppl 1():127-32. PubMed ID: 1654293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative immunogenicity and thrombolytic properties toward arterial and venous thrombi of streptokinase and recombinant staphylokinase in baboons.
    Collen D; De Cock F; Stassen JM
    Circulation; 1993 Mar; 87(3):996-1006. PubMed ID: 8443918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The importance of enzyme inhibition kinetics for the effect of thrombin inhibitors in a rat model of arterial thrombosis.
    Elg M; Gustafsson D; Deinum J
    Thromb Haemost; 1997 Oct; 78(4):1286-92. PubMed ID: 9364999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban.
    Finkle CD; St Pierre A; Leblond L; Deschenes I; DiMaio J; Winocour PD
    Thromb Haemost; 1998 Feb; 79(2):431-8. PubMed ID: 9493603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective factor Xa inhibition by recombinant antistasin prevents vascular graft thrombosis in baboons.
    Schaffer LW; Davidson JT; Vlasuk GP; Dunwiddie CT; Siegl PK
    Arterioscler Thromb; 1992 Aug; 12(8):879-85. PubMed ID: 1637785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates.
    Hanson SR; Griffin JH; Harker LA; Kelly AB; Esmon CT; Gruber A
    J Clin Invest; 1993 Oct; 92(4):2003-12. PubMed ID: 8408654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective inhibition by a synthetic hirudin peptide of fibrin-dependent thrombosis in baboons.
    Cadroy Y; Maraganore JM; Hanson SR; Harker LA
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1177-81. PubMed ID: 1996320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterisation of a novel series of aprotinin-derived anticoagulants. II. Comparative antithrombotic effects on primary thrombus formation in vivo.
    Stassen JM; Lambeir AM; Vreys I; Deckmyn H; Matthyssens G; Nyström A; Vermylen J
    Thromb Haemost; 1995 Aug; 74(2):655-9. PubMed ID: 8585002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biologic effects of recombinant hirudin (CGP 39393) in human volunteers. European Hirudin in Thrombosis Group.
    Verstraete M; Nurmohamed M; Kienast J; Siebeck M; Silling-Engelhardt G; Büller H; Hoet B; Bichler J; Close P
    J Am Coll Cardiol; 1993 Oct; 22(4):1080-8. PubMed ID: 8409044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relative efficacy of antithrombin compared with antiplatelet agents in accelerating coronary thrombolysis and preventing early reocclusion.
    Haskel EJ; Prager NA; Sobel BE; Abendschein DR
    Circulation; 1991 Mar; 83(3):1048-56. PubMed ID: 1900222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor.
    Heras M; Chesebro JH; Penny WJ; Bailey KR; Badimon L; Fuster V
    Circulation; 1989 Mar; 79(3):657-65. PubMed ID: 2521818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antithrombotic effects of combining activated protein C and urokinase in nonhuman primates.
    Gruber A; Harker LA; Hanson SR; Kelly AB; Griffin JH
    Circulation; 1991 Dec; 84(6):2454-62. PubMed ID: 1835678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.